The fate of MAb-targeted Cd125mTe/ZnS nanoparticles in vivo

Nuclear Medicine and Biology

Volumn 35, Issue 4, 2008, Pages 501-514

  Kennel, Stephen J ^a   Woodward, Jonathan D ^b   Rondinone, Adam J ^b   Wall, Jonathan ^a   Huang, Ying ^a   Mirzadeh, Saed ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

Antibody targeted; Cd125mTe; Clodronate; Nanoparticles; SPECT CT

Indexed keywords

CADMIUM DERIVATIVE; CLODRONIC ACID; LIPOSOME; MONOCLONAL ANTIBODY 201B I 125; MONOCLONAL ANTIBODY 201B TE 125M; MONOCLONAL ANTIBODY 33 TE 125M; NANOPARTICLE; QUANTUM DOT; RADIOPHARMACEUTICAL AGENT; THIOGLYCOLIC ACID; THROMBOMODULIN; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG RETENTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; IN VIVO STUDY; ISOTOPE LABELING; LIVER; LUNG; LUNG BLOOD VESSEL; MOUSE; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; RETICULOENDOTHELIAL SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTORADIOGRAPHY; BLOOD VESSELS; CADMIUM COMPOUNDS; CLODRONIC ACID; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; LUNG; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; NANOPARTICLES; PHAGOCYTES; RADIOIMMUNODETECTION; RADIOISOTOPES; RADIONUCLIDE ANGIOGRAPHY; RADIOPHARMACEUTICALS; TELLURIUM; THROMBOMODULIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ZINC SULFATE;

EID: 43049159558     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.02.001     Document Type: Article

References (38)

1. Hughes B.J., Kennel S., Lee R., and Huang L. Monoclonal antibody targeting of liposomes in mouse lung in vivo. Cancer Res 49 (1989) 6214-6220
2. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 66 (2006) 6732-6740
3. Ballot S., Noiret N., Hindre F., Denizot B., Garin E., Rajerison J., et al. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur J Nucl Med Mol Imaging 33 (2006) 602-607
4. 111In nanoparticles. Int J Cancer 120 (2007) 1951-1957
5. Bibby D.C., Talmadge J.E., Dalal M.K., Kurz S.G., Chytil K.M., Barry S.E., et al. Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice. Int J Pharm 293 (2005) 281-290
6. Fang C., Shi B., Pei Y.Y., Jong M.H., Wu J., and Chem H.Z. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur Pharm Sci 27 (2006) 27-36
7. Cheng J., Teply B.A., Sherifi I., Sung J., Luther G., Gu F.X., et al. Formulation of functionalized LGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28 (2007) 869-876
8. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med 46 (2005) 1210-1218
9. Hamoudeh M., Salim H., Barbos D., Paunoiu C., and Fessi H. Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intra-tumor therapy. Eur J Pharm Biopharm (2007) [electronic publication]
10. Kommareddy S., and Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J Pharma Sci 96 (2007) 397-407
11. Zielhuis S.W., Nijsen J.F.W., Seppenwoolde J.H., Zonnenberg B.A., Bakker C.J.G., Hennink W.E., et al. Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancer. Curr Med Chem 5 (2005) 303-313
12. Smith B.R., Heverhagen J., Knopp M., Schmalbrock P., Shapiro J., Shiomi M., et al. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices (2007) [electronic publication]
13. Alexiou C., Jurgons R., Schmid R.J., Bergemann C., Henki J., Erhardt W., et al. Magnetic drug targeting - biodistribution for the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 11 (2003) 139-149
14. Medarova Z., Pham W., Ferrar C., Petkova V., and Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 13 (2007) 372-377
15. Bai S., Thomas C., Rawat A., and Ahsan F. Recent progress in dendrimer-based nanocarriers. Crit Rev Ther Drug Carrier Syst 23 (2006) 437-495
16. Reilly R.M. Carbon nanotubes: potential benefits and risks of nanotechnology in nuclear medicine. J Nucl Med 48 (2007) 1039-1042
17. McDevitt M.R., Chattopadhyay D., Kappel B.J., Jaggi J.S., Schiffman S.R., Antczak C., et al. Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J Nucl Med 48 (2007) 1180-1189
18. Tada J., Higuchi H., Wanatabe T.M., and Ohuchi N. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res 67 (2007) 1138-1144
19. 125mTe/ZnD nanoparticles. Nanotechnology 18 (2007) 1-5
20. Schipper M.L., Cheng Z., Lee S.W., Bentolila L.A., Iyer G., Rao J., et al. MicroPET-based biodistribution of quantum dots in living mice. J Nucl Med 48 9 (2007) 1511-1518
21. Cai W., Chen K., Li Z.B., Gambhir S., and Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 48 (2007) 1862-1870
22. 64Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. Biomacromolecules 8 (2007) 3126-3134
23. Owens III D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307 (2006) 93-102
24. Kennel S.J., Lee R., Bultman S., and Kabalka G. Rat monoclonal antibody distribution in mice: an epitope inside the lung vascular space mediates very efficient localization. Nucl Med Biol 17 (1990) 193-200
25. Date A.A., Joshi M.D., and Patravale V.B. Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 10 (2007) 1016-1032
26. Chen J., Wu H., Han D., and Xie C. Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer. Cancer Lett 231 (2006) 169-175
27. 213Bi. Brit J Cancer 80 (1999) 175-184
28. Klibanov A.L., Maruyama K., Beckerleg A.M., Torchilin V.P., and Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposomes binding to target. Biochim Biophys Acta 1062 2 (1991) 142-148
29. Wong D.M., and Varesio L. Depletion of macrophages from heterogeneous cell populations by the use of carbonyl iron. Methods Enzymol 108 (1984) 307-313
30. Sanderson C.J., and Taylor G.A. Antibody-dependent cell-mediated cytotoxicity in the rat. The role of macrophages. Immunology 30 (1976) 117-121
31. Van Rooijen N. The liposome-mediated macrophage 'suicide' technique. J Immunol Methods 124 (1989) 1-6
32. Lasbury M.E., Durant P.J., Ray C.A., Tschang D., Schwendener R., and Lee C.H. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia. J Immunol 186 (2006) 6443-6453
33. 213Bi]-MAb TES-23. Eur J Cancer 38 (2002) 1278-1287
34. Wall J.S., Kennel S.J., Paulus M., Gregor J., Richey T., Avenell J., et al. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J Nucl Med 47 (2006) 2016-2024
35. Ponta J., Wainwright D., and Herrlich P. The CD44 protein family. Int J Biochem Cell Biol 30 (1998) 299-305
36. Kennel S.K., Lankford T., Hughes B., and Hotchkiss J.A. Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. Lab Invest 59 (1988) 692-701
37. Mason M.D., Sydes M.R., Glaholm J., Langley R.E., Huddart R.A., Sokal M., et al. Oral sodium clodronate for nonmetastatic prostate cancer - results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN16384873). J Natl Cancer Inst 99 10 (2007) 765-776
38. Lovric J., Bazzi H., Cuie Y., Fortin G.R., Winnik F.M., and Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83 (2005) 377-385